Active Immunization, the cornerstone of modern medicine, epitomizes humanity's triumph over infectious diseases. Through the administration of vaccines, the body's immune system is stimulated to recognize and combat specific pathogens, thereby building a robust defense against future encounters. This proactive approach not only shields individuals but also contributes to community-wide immunity, known as herd immunity, which protects those who cannot be vaccinated. Vaccines come in various forms, from live attenuated viruses to inactivated pathogens, as well as subunit vaccines, recombinant vaccines, and mRNA vaccines, each tailored to provoke a targeted immune response. They are meticulously developed and rigorously tested to ensure safety and efficacy, undergoing phases of clinical trials before regulatory approval.
The impact of vaccines on public health cannot be overstated. Diseases like smallpox and polio, once rampant, have been virtually eradicated through widespread vaccination campaigns. Vaccines have prevented countless deaths and disabilities, enabling children to thrive and communities to flourish. In recent times, vaccines have played a pivotal role in combating emerging infectious threats, such as influenza, measles, and COVID-19. They are instrumental in curbing outbreaks, protecting vulnerable populations, and restoring societal stability.
However, vaccine hesitancy and misinformation pose significant challenges to global immunization efforts. Addressing these concerns requires robust education, transparent communication, and equitable access to vaccines for all communities.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Awareness and acceptability of rotavirus vaccine among mothers of under-five children in Gusau and Bungudu communities of Zamfara State, Northwestern Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil